In September 2025, Citest Diagnostics released the innovative Multiplex Respiratory Antigen Rapid Test (Swab)--a cutting-edge chromatographic immunoassay designed for professional in vitro diagnostic use only. This test aims to qualitatively detect multiple respiratory infectious diseases in human swab specimens, aiding timely diagnosis by targeting antigens of key pathogens including Adenovirus, HPIV, RSV, SARS-CoV-2, M.pneumoniae, RhV, Flu A/B and HMPV --all of which cause various respiratory illnesses across different age groups.
Leveraging advanced chromatographic immunoassay technology, the Multiplex Respiratory Antigen Rapid Test enables simultaneous identification of antigens from multiple respiratory pathogens, meeting the demand for thorough diagnostic assessment in respiratory care. Notably, it delivers results in just 15 minutes, drastically streamlining workflows and reducing wait times for both patients and healthcare providers.
The test excels in four core advantages: it offers broad spectrum detection to cover a wider range of respiratory pathogens for comprehensive diagnosis of multiple infections; it saves time with 15-minute result delivery to accelerate clinical processes; it ensures high-quality diagnostics via advanced technology for accurate, reliable results that inform timely treatment decisions; and it is cost-effective by reducing the need for multiple individual tests, cutting costs for laboratories and healthcare facilities.
In conclusion, Citest’s Multiplex Respiratory Antigen Rapid Test (Swab) reimagines respiratory disease diagnostics by integrating broad detection capabilities, rapid result delivery, high accuracy, and cost efficiency. By addressing the critical need for swift and comprehensive identification of respiratory pathogens, this test enhances clinical decision-making and supports effective infection control strategies. This launch underscores Citest Diagnostics’ dedication to developing innovative diagnostic solutions that protect public health and improve patient outcomes globally.
